The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic

BJUI Compass. 2022 May 17;3(5):324-326. doi: 10.1002/bco2.153. eCollection 2022 Sep.

Beth Russell¹, Sarah Spencer-Bowdage², Jeannie Rigby², Jackie O'Kelly², Phil Kelly², Mark Page², Caroline Raw², Paula Allchorne^{2

3}, Peter Harper^{2

4}, Jeremy Crew^{2

5}, Roger Kockelbergh^{2

6

7}, Allen Knight^{2

8}, Mieke Van Hemelrijck¹, Richard T Bryan^{2

9}

¹ Translational Oncology and Urology Research King's College London London UK.
² Action Bladder Cancer UK Tetbury UK.
³ Barts Health NHS Trust London UK.
⁴ Leaders in Oncology Care London UK.
⁵ Oxford University Hospitals NHS Foundation Trust Oxford UK.
⁶ University Hospitals of Leicester NHS Trust Leicester UK.
⁷ Leicester Cancer Research Centre University of Leicester Leicester UK.
⁸ World Bladder Cancer Patient Coalition Brussels Belgium.
⁹ Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences University of Birmingham Birmingham UK.

No abstract available

Keywords: COVID‐19; bladder cancer; patient experience; survey.